Rachel Storr

Dicerna Pharmaceuticals (United States) — United States

Medicine · Health Sciences

3h-index143citations3works0.02yr avg

OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Kidney Stones and Urolithiasis Treatments(1), Carbohydrate Chemistry and Synthesis(1), Click Chemistry and Applications(1), Genetics and Neurodevelopmental Disorders(1), Cassava research and cyanide(1)

Publications3 total

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria

104 cited

Molecular Therapy·2018· 104 citedOpen Access

Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases

33 cited

Molecular Therapy·2018· 33 citedOpen Access

Abstract 2925: Anti-tumor activity of a MYC-targeting dicer substrate siRNA in combination with BRD4/CDK7 inhibitors

6 cited

Cancer Research·2016· 6 cited

Frequent Co-authors

Bo Young Kim(3), Weimin Wang(3), Marc Abrams(3), Cheng-Jung Lai(2), Natalie W. Pursell(2), Jessica J. Gierut(2), Utsav Saxena(2), Wei Zhou(2), Michael Dills(2), Rohan Diwanji(2), Henryk Dudek(2), Bob D. Brown(2), Anee Shah(2), Chaitali Dutta(1), Martin L. Koser(1), Naim Nazef(1), Cristina Martín-Higueras(1), Eduardo Salido(1), Monika Gjorgjieva(1), Jr-Shiuan Yang(1)